| Q34626341 | Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy |
| Q43112996 | Acute neurosteroids inhibit the spinal reflex potentiation via GABAergic neurotransmission |
| Q38571198 | Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know? |
| Q36532945 | Age-related changes in neuroactive steroid levels in 3xTg-AD mice. |
| Q93050900 | Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage |
| Q91610622 | Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study |
| Q21144864 | An ARHGEF10 deletion is highly associated with a juvenile-onset inherited polyneuropathy in Leonberger and Saint Bernard dogs |
| Q30434049 | Are neuroactive steroids promising therapeutic agents in the management of acute and chronic pain? |
| Q91921015 | Atypical gene expression of neuroinflammatory and steroid related genes following injury in the photoperiodic Japanese quail |
| Q36222769 | Can progesterone be a better alternative to dexamethasone for use in routine brain surgery? |
| Q49568258 | Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes. |
| Q39709025 | Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy. |
| Q47273458 | Could gonadal and adrenal androgen deficiencies contribute to the depressive symptoms in men with systolic heart failure? |
| Q61806582 | Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines |
| Q43116171 | Dihydroprogesterone increases the gene expression of myelin basic protein in spinal cord of diabetic rats |
| Q51737507 | Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause. |
| Q39428788 | Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review. |
| Q92104846 | From Cannabinoids and Neurosteroids to Statins and the Ketogenic Diet: New Therapeutic Avenues in Rett Syndrome? |
| Q37991787 | Gonadal hormones and the control of reactive gliosis. |
| Q46361354 | Growth of white matter in the adolescent brain: role of testosterone and androgen receptor |
| Q92959712 | Liver X Receptors and Their Implications in the Physiology and Pathology of the Peripheral Nervous System |
| Q38101013 | Liver X receptors, nervous system, and lipid metabolism. |
| Q38877219 | Long-term effects of prenatal progesterone exposure: neurophysiological development and hospital admissions in twins up to 8 years of age. |
| Q91796591 | Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway |
| Q48514095 | Milestones on Steroids and the Nervous System: 10 years of basic and translational research. |
| Q84356777 | Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease |
| Q47294316 | Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis. |
| Q58874343 | Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients |
| Q39455313 | Neuroactive steroids and diabetic complications in the nervous system. |
| Q38396464 | Neuroactive steroids and the peripheral nervous system: An update. |
| Q45920953 | Neuromodulatory effect of progesterone on the dopaminergic, glutamatergic, and GABAergic activities in a male rat model of Parkinson's disease. |
| Q58874376 | Neuroprotective Effects of Progesterone in Chronic Experimental Autoimmune Encephalomyelitis |
| Q37238625 | Neuroprotective actions of brain aromatase |
| Q35049356 | Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms |
| Q38096797 | Neurosteroid and neurotransmitter alterations in Parkinson's disease |
| Q90342576 | Neurosteroids and neuropathic pain management: Basic evidence and therapeutic perspectives |
| Q58586871 | Neurosteroids in Pain Management: A New Perspective on an Old Player |
| Q38024835 | Novel actions of progesterone: what we know today and what will be the scenario in the future? |
| Q37198664 | Oestradiol synthesized by female neurons generates sex differences in neuritogenesis. |
| Q37288746 | Pathogenesis and treatment of pruritus in cholestasis |
| Q37519719 | Pharmacotherapy for women's sexual dysfunction |
| Q90685179 | Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites |
| Q88416994 | Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin? |
| Q36404957 | Prenatal particulate air pollution and neurodevelopment in urban children: Examining sensitive windows and sex-specific associations |
| Q38651398 | Prenatal particulate air pollution exposure and body composition in urban preschool children: examining sensitive windows and sex-specific associations |
| Q28582085 | Regulatory role of cytochrome P450scc and pregnenolone in myelination by rat Schwann cells |
| Q35972151 | Role of neuroactive steroids in the peripheral nervous system |
| Q36520350 | Selective regulation of neurosteroid biosynthesis under ketamine-induced apoptosis of cortical neurons in vitro |
| Q37432182 | Sex and the development of Alzheimer's disease. |
| Q37625151 | Sex differences in anxiety and depression: role of testosterone |
| Q45307726 | Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. |
| Q91123514 | Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role |
| Q38471576 | Sex differences in the injured brain. |
| Q36426980 | Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein |
| Q37518569 | Sex-specific therapeutic strategies based on neuroactive steroids: In search for innovative tools for neuroprotection. |
| Q91582200 | Short-term sleep fragmentation enhances anxiety-related behavior: The role of hormonal alterations |
| Q55333269 | Steroid Hormones and Their Action in Women's Brains: The Importance of Hormonal Balance. |
| Q35818527 | Steroid Receptor Isoform Expression in Drosophila Nociceptor Neurons Is Required for Normal Dendritic Arbor and Sensitivity |
| Q48723982 | Steroidogenic acute regulatory protein in white sturgeon (Acipenser transmontanus): cDNA cloning, sites of expression and transcript abundance in corticosteroidogenic tissue after an acute stressor |
| Q39703211 | Steroids, spinal cord and pain sensation. |
| Q38806983 | Sterol regulatory element binding protein-1C knockout mice show altered neuroactive steroid levels in sciatic nerve. |
| Q38208207 | Structure-activity relationship studies on neuroactive steroids in memory, alcohol and stress-related functions: a crucial benefit from endogenous level analysis |
| Q35169910 | Synthetic neurosteroids on brain protection |
| Q36327962 | Testosterone therapy for reduced libido in women |
| Q35201430 | The biological basis of injury and neuroprotection in the fetal and neonatal brain |
| Q41438243 | The effect of the steroid sulfatase inhibitor (p-O-sulfamoyl)-tetradecanoyl tyramine (DU-14) on learning and memory in rats with selective lesion of septal-hippocampal cholinergic tract |
| Q38271320 | The neuroprotective actions of oestradiol and oestrogen receptors |
| Q48548114 | The neurosteroid pregnenolone reverts microtubule derangement induced by the loss of a functional CDKL5-IQGAP1 complex |
| Q48361555 | Therapeutic implications of brain steroidogenesis |
| Q90751077 | Weak correlations between serum and cerebrospinal fluid levels of estradiol, progesterone and testosterone in males |